Patient-based utilities for bipolar disorder-related health states

被引:29
|
作者
Revicki, DA
Hanlon, J
Martin, S
Laszlo, GC
Ghaemi, SN
Lynch, F
Mannix, S
Kleinman, L
机构
[1] United Biosource Corp, Ctr Hlth Outcomes Res, METAP Inst, Bethesda, MD 20814 USA
[2] J&J Pharmaceut Sci, Raritan, NJ USA
[3] Univ Penn, Biopolar Disorders Program, Philadelphia, PA 19104 USA
[4] Harvard Univ, Sch Med, Dept Psychiat, Cambridge Hosp, Cambridge, MA 02138 USA
[5] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA
[6] MEDTAP Int, Ctr Hlth Outcomes Res, Seattle, WA USA
关键词
bipolar disorder; utility assessment; level of functioning; treatment-related side effects;
D O I
10.1016/j.jad.2005.03.017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Bipolar disorder is a psychiatric disorder which impacts patient functioning and well-being. With increasing interest in cost-effectiveness of treatments, it is necessary to provide estimates of patient's perspectives on treatment outcomes. This study estimated health state utilities for hypothetical bipolar-related health states and patient's current health from bipolar I patients. Methods: Clinicians completed Young Mania Rating Scale, Montgomery-Asberg Depression Rating Scale, and Global Assessment Score. Patients completed structured standard gamble (SG) utility assessment interviews, and the other patient-based measures. Interviews obtained utilities for hypothetical bipolar-related health states describing symptom severity, functioning and well-being, and treatment-related side effects. Results: Ninety-six patients were recruited from psychiatry outpatient practices. Mean utilities for inpatient states ranged from 0.12 to 0.33; outpatient mania states ranged from 0.29 to 0.64; outpatient stable states ranged from 0.53 to 0.85. Mean utility for current health was 0.80 (S.D.=0.22). Patients preferred monotherapy compared with combination therapy health states. Ordinary least squares regression indicated weight gain was associated with a 0.066 decrease in health state utilities (P=0.013). Limitations: Study sample consisted of selected stable and educated patients and small sample sizes may limit generalizability for some utilities. Conclusions: Bipolar disorder patients are capable of participating in utility assessment and providing ratings for hypothetical health states associated with different mood stabilizer treatments. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [31] Development and validation of a French patient-based health-related quality of life instrument in kidney transplant: the ReTransQoL
    Stéphanie Gentile
    Elisabeth Jouve
    Bertrand Dussol
    Valerie Moal
    Yvon Berland
    Roland Sambuc
    Health and Quality of Life Outcomes, 6
  • [32] Integrating patient preferences with health utilities - A variation on health-related quality of life
    VanBeek, Marta J.
    ARCHIVES OF DERMATOLOGY, 2008, 144 (08) : 1037 - 1041
  • [33] Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia:: the S-QoL
    Auquier, P
    Simeoni, MC
    Sapin, C
    Reine, G
    Aghababian, V
    Cramer, J
    Lançon, C
    SCHIZOPHRENIA RESEARCH, 2003, 63 (1-2) : 137 - 149
  • [34] Development and validation of a French patient-based health-related quality of life instrument in kidney transplant: the ReTransQoL
    Gentile, Stephanie
    Jouve, Elisabeth
    Dussol, Bertrand
    Moal, Valerie
    Berland, Yvon
    Sambuc, Roland
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2008, 6 (1)
  • [35] Patient-based Cultural Competency Curriculum for Pre-Health Professionals
    Melamed, Esther
    Wyatt, Lacey E.
    Padilla, Tony
    Ferry, Robert J., Jr.
    FAMILY MEDICINE, 2008, 40 (10) : 726 - 733
  • [36] A patient-based utility measure of health for clinical trials of cancer therapy
    Pickard, A. S.
    Shaw, J. W.
    Lin, H.
    Trask, P. C.
    Aaronson, N. K.
    Lee, T. A.
    Cella, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] AN EVALUATION OF THE PREVALENCE OF DIAGNOSED OPIOID USE DISORDER AND THE ECONOMIC BURDEN OF OPIOID USE DISORDER-RELATED HEALTHCARE COSTS IN THE UNITED STATES
    Schoenfeld, A. J.
    Geiger, J.
    Princic, N.
    Moynihan, M.
    Varker, H.
    Wang, Z.
    Shi, L.
    Stiegler, M.
    Menzie, A. M.
    VALUE IN HEALTH, 2024, 27 (06) : S103 - S103
  • [38] Posttraumatic stress disorder-related anhedonia as a predictor of psychosocial functional impairment among United States veterans
    May, Casey L.
    Wisco, Blair E.
    Fox, Victor A.
    Marx, Brian P.
    Keane, Terence M.
    JOURNAL OF TRAUMATIC STRESS, 2022, 35 (05) : 1334 - 1342
  • [39] Predicting Patient-Based Time-Dependent Mobile Health Data
    Kleinau, Anna
    Fluegel, Simon
    Pryss, Ruediger
    Vogel, Carsten
    Engelke, Milena
    Schlee, Winfried
    Unnikrishnan, Vishnu
    Spiliopoulou, Myra
    2023 IEEE 36TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, CBMS, 2023, : 79 - 84
  • [40] MEASUREMENT OF UTILITIES FOR HEALTH STATES RELATED TO ANDROGEN DEPENDENT PROSTATE CANCER IN KOREA
    Jeung, S.
    Chang, C.
    Jun, J. H.
    Lee, S. R.
    Suh, D.
    VALUE IN HEALTH, 2016, 19 (03) : A158 - A158